Invention Grant
US09238656B2 Imidazo[4,5-b]pyridine derivatives as ALK and JAK modulators for the treatment of proliferative disorders
有权
咪唑并[4,5-b]吡啶衍生物作为ALK和JAK调节剂用于治疗增殖性疾病
- Patent Title: Imidazo[4,5-b]pyridine derivatives as ALK and JAK modulators for the treatment of proliferative disorders
- Patent Title (中): 咪唑并[4,5-b]吡啶衍生物作为ALK和JAK调节剂用于治疗增殖性疾病
-
Application No.: US14446411Application Date: 2014-07-30
-
Publication No.: US09238656B2Publication Date: 2016-01-19
- Inventor: Henry J. Breslin , Matthew A. Curry , Diane E. Gingrich , Keith S. Learn , Gregory R. Ott , Jason C. Wagner
- Applicant: Cephalon, Inc.
- Applicant Address: US PA Frazer
- Assignee: Cephalon, Inc.
- Current Assignee: Cephalon, Inc.
- Current Assignee Address: US PA Frazer
- Main IPC: C07D493/08
- IPC: C07D493/08 ; C07D491/107 ; C07D471/04 ; A61K31/47 ; A61K31/437 ; A61K31/444 ; A61K31/4545 ; A61K31/496 ; A61K31/506 ; A61K31/5377 ; A61P35/00
![Imidazo[4,5-b]pyridine derivatives as ALK and JAK modulators for the treatment of proliferative disorders](/abs-image/US/2016/01/19/US09238656B2/abs.jpg.150x150.jpg)
Abstract:
This application relates to compounds of the Formula I as defined herein, and/or salts thereof. This application further relates to compositions and methods of using these compounds and/or salts thereof. The compounds of Formula I are useful as ALK and JAK modulators for the treatment of proliferative disorders.
Public/Granted literature
Information query